Literature DB >> 2916376

Thyroid function in hyperemesis gravidarum.

R Swaminathan1, R K Chin, T T Lao, Y T Mak, N S Panesar, C S Cockram.   

Abstract

Plasma total T4 (TT4), T3 (TT3), free T4 (FT4), free T3 (FT3), thyroxine binding globulin, hCG, and erythrocyte zinc content were measured in 43 women with uncomplicated pregnancy and in 71 patients admitted with hyperemesis gravidarum. Plasma concentration of thyroid hormones in hyperemesis subjects showed wide variability and 32% of subjects had high TT4 (higher than mean +2 SD of normal pregnant subjects), 33% had high FT4, 20% had high TT3, and 20% had high FT3. Red cell zinc content, a tissue marker of thyroid status, in the hyperthyroxinemic subjects was not different from that of normothyroxinemic hyperemesis subjects or of subjects with uncomplicated pregnancy. The elevated TT4 concentration decreased spontaneously in all but two of the hyperemesis subjects to normal pregnant levels. The plasma FT4 concentration at presentation correlated with plasma hCG in hyperemesis gravidarum (partial correlation coefficient r = 0.411, P less than 0.01), but not in normal pregnancy (partial correlation coefficient r = 0.043) after allowing for the effect of gestational age. We conclude that approximately one third of hyperemesis subjects show transient hyperthyroxinemia and suggest that hCG or a molecular variant of hCG may stimulate the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916376     DOI: 10.1530/acta.0.1200155

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  5 in total

1.  Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum.

Authors:  Patrick M Mullin; ChunYu Ching; Frederic Schoenberg; Kimber MacGibbon; Roberto Romero; T Murphy Goodwin; Marlena S Fejzo
Journal:  J Matern Fetal Neonatal Med       Date:  2011-09-15

2.  Hyperthyroidism from an embryonal carcinoma.

Authors:  R Gama; M G Smith; W F White; P Kwong
Journal:  J R Soc Med       Date:  1997-08       Impact factor: 5.344

Review 3.  Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.

Authors:  P Atkins; S B Cohen; B J Phillips
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

Review 4.  Treatment of hyper- and hypothyroidism in pregnancy.

Authors:  J H Lazarus
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

5.  Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy.

Authors:  D Glinoer; P De Nayer; C Robyn; B Lejeune; J Kinthaert; S Meuris
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.